Organophosphate
OtherChlorpyrifos 50% plus cypermethrin 5%, WHO Class II: Moderately hazardous
NCT Number: NCT02838303
The purpose of this study is to evaluate self-reported symptoms as a proxy for acute organophosphate poisoning by examining self-reported acute organophosphate poisoning symptoms and PchE activity in response to occupational acute organophosphate exposure among farmers in Nepal.
Looking for future studies?
Notify Me18 year and older
Male
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Chlorpyrifos 50% plus cypermethrin 5%, WHO Class II: Moderately hazardous
Multineem, WHO Class U: Unlikely to present acute hazard in normal use
Other names: Biopesticide
Time frame: Obtained just before (baseline) and 30 minutes after (baseline) each spray session
Obtained using a structured questionnaire interview. The definition of symptoms was based on WHO's standardized list of clinical presentations of acute organophosphate poisoning.
Time frame: Obtained just before (baseline) and 30 minutes after (baseline) each spray session
PchE activity was measured with a blood test using a Test-mate Che Cholinesterase System (Model 400) with a PchE Plasma Cholinesterase Assay Kit (Model 470).
Bispebjerg Hospital
Other
The Use of Self-reported Symptoms as a Proxy for Acute Organophosphate Poisoning Among Nepali Farmers: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03564574
Chemically-Induced Disorders, Organophosphate Poisoning
Chandigarh, India
View Trial DetailsNCT02147054
Chemically-Induced Disorders, Organophosphate Poisoning
Peradeniya, Central Province, Sri Lanka
View Trial DetailsNCT02160548
Chemically-Induced Disorders, Organophosphate Poisoning
Sylhet, Sylhet Division, Bangladesh
View Trial DetailsNCT02137317
Chemically-Induced Disorders, Organophosphate Poisoning
Bharatpur, Chitwan, Nepal
View Trial Details